Michael La Fountaine , EdD, ATC, FACSM
Associate Dean of Academic Affairs and Research, and Professor
Department of Physical Therapy
(973) 275-2918
Email
Interprofessional Health Sciences Campus
Room 436
Michael La Fountaine, EdD, ATC, FACSM
Associate Dean of Academic Affairs and Research, and Professor
Department of Physical Therapy
I joined the Department of Physical Therapy faculty at Seton Hall University in the Fall of 2011 and provide instruction on courses that encompass physiology and pharmacology. In addition to my role in the Department of Physical Therapy, I am also associated with Seton Hall-Hackensack Meridian School of Medicine. As my formal education becomes an increasingly distant memory, I feel a greater sense of awe and wonderment of the privilege and promise that higher education has brought to my life. I garnered opportunities through intense planning, hard work, luck and being receptive to the wisdom imparted by my many professors and mentors. I learned early, that as an academician, it is imperative that the fundamentals of curiosity and objectivity are co-developed. This mindset is necessary for the pursuit of knowledge as a student of life. Finding joy and satisfaction through the tedium of a rigorous academic or training curriculum, though tricky, enhanced my sense of achievement upon completion and assisted me with obtaining self-actualization in personal and professional life. Being able to share my experiences and help students attain the same level of satisfaction with their academic pursuits and professional interests have fueled my desire to become a professor and mentor.
To best explain my research interests and focus, I offer that I am an autonomic physiologist who is interested in understanding how traumatic neurological injuries affect endocrine function in the cardiovascular system. I am actively involved in research projects to explain the secondary medical consequences of spinal cord injury and identify targeted rehabilitation or pharmaceutical therapy to offset these deleterious changes. Although my primary research cohort is that of individuals with spinal cord injury, I've been intrigued by and continue to investigate the pathophysiology of concussion(s) among athletes who sustained an injury as a result of sport. I also have an interest in the use of research investigation(s) as an education tool in developing skills that are relevant to clinical practice.
Click here for Michael LaFountaine's Bibliography
Education
- Ed.D., Columbia University, 2008
- M.Ed., Columbia University, 2005
- M.A., Columbia University, 2003
- B.S., Alfred University, 2001
Scholarship
- La Fountaine MF, Cirnigliaro CM, Hobson JC, Lombard AT, Specht AF, Dyson-Hudson TA, Bauman WA. A Randomized Controlled Trial to Assess the Efficacy of Four Months of Once-daily Fenofibrate Monotherapy to Lower the Serum Triglyceride Concentrations in Persons with Spinal Cord Injury. Scientific Reports, 2019. 9(1): 17166.
- La Fountaine MF, Hill-Lombardi V, Hohn AN, Leahy CL, Testa AJ. Preliminary Evidence for a Window of Increased Vulnerability to Sustain a Concussion in Females: A Brief Report. Frontiers in Neurology, 2019. 10: 691.
- La Fountaine MF, Hohn AN, Testa A, Weir JP. Attenuation of Spontaneous Baroreceptor Sensitivity following Concussion. Medicine and Science in Sports and Exercise, 2019. 51(4): 792-797.
- La Fountaine MF, Cirnigliaro CM, Hobson JC, Dyson-Hudson TA, McKenna C, Kirshblum SC, Spungen AM, Bauman WA. Establishing a threshold to predict risk of cardiovascular disease from the serum triglyceride and high-density lipoprotein concentrations in persons with spinal cord injury. Spinal Cord (Nature), 2018. 56(11): 1051-1058.
- La Fountaine MF. Anatomical and Physiological Basis for the Cardiovascular Autonomic Nervous System Consequences of Sport-Related Brain Injury (Invited Review). International Journal of Psychophysiology, 2018. 132 (Part A): 155-166.
Accomplishments
Grants
- Principal Investigator: Evaluating the Role of Baroreceptor Sensitivity in the Post-Concussive Symptomatic Milieu. New Jersey Commission for Brain Injury Research- Individual Research Grant; CBIR16IRG025; 07/01/2016 – 12/31/2021
- Co-Investigator: Abaloparatide to Improve Bone Mineral Density and Architecture in SCI. New York State Department of Health and New York Spinal Cord Injury Research Board; DOH01-C34461GG-3450000; 05/01/2019 – 04/30/2022
- Co-Investigator: Treatment with Romosozumab to Improve Bone Mineral Density and Architectural Integrity in Persons with Chronic SCI. VA RR&D IIR Merit Review; 1I01RX003415-01; 06/01/2020 – 05/31/2024
Awards
- 2020 Seton Hall University Researcher of the Year
- 2020, 2018, 2014 School of Health and Medical Sciences Researcher of the Year
- 2013 New Investigator Award, American College of Sports Medicine
Fellowship
- 2018 Fellow, American College of Sports Medicine